Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score

NCT04943991 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT04943991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04943991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score
Lead sponsor
Wuerzburg University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2021
Completion date
October 1, 2024
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anderson fabry disease, fabry disease, fabry disease, cardiac variant, hcm - hypertrophic cardiomyopathy, lysosomal storage diseases